Mar 29, 2018

Dr. Robert Pearl is the former CEO of the Permanente Medical Group (1999-2017), the nation’s largest medical group, and former president of the Mid-Atlantic Permanente Medical Group (2009-2017). In these roles, he led 9,000 physicians, 35,000 staff, and was responsible for the nationally recognized medical care of 4...

Mar 22, 2018

Prior to Aventria, David held several commercial leadership roles, including Head of Oncology Marketing at Genentech and VP Strategic Marketing at Schering AG, specializing in commercializing oncology and specialty products. He was also instrumental in the commercialization of Taxotere, Fludara, Herceptin, and Rituxan.

Mar 15, 2018

Julie is an executive pharmaceutical leader with over 20 years of experience across all phases of development both on the commercial and research sides of the organization. She leverages her Masters in Business Administration and Doctorate of Pharmacy to develop and deliver strategic patient-centric value propositions...

Mar 8, 2018

Wayne Crandall is the president and CEO of NoteSwift. Crandall's career in technology spans sales, marketing, product management, strategic development, and operations. Prior to joining the NoteSwift team, Crandall was president and CEO of CYA Technologies, and then took over as president of enChoice, which specialized...

Mar 1, 2018

Moore, is CEO of the health care IT analyst firm, Chilmark Research, which he founded in 2007. Chilmark Research was founded on the simple premise of conducting the best research possible that will ultimately lead to improvements in the quality of care a patient receives. Having spent many years in other industry...